Phenominer Database Results (39 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
F344 number of abdominal retractions Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 7 57.75 null 27.0 71.44 visual assessment of in vivo video recording 1500.0 stretch/retract abdomon 105551 3018
F344 number of abdominal retractions 4-methyl-2-(piperidin-1-yl)-quinoline (1 mg/kg) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 4 10.66 null 5.4 10.8 visual assessment of in vivo video recording 1500.0 stretch/retract abdomon 105559 3018
F344 number of abdominal retractions sucrose (10 %) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 4 82.5 null 12.22 21.17 visual assessment of in vivo video recording 1500.0 retract abdomen 105562 3018
F344 mean arterial blood pressure 4-methyl-2-(piperidin-1-yl)-quinoline (1 mg/kg) (for 1 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. arterial blood pressure trait male  days 3 98.16 mmHg unspecified method 0.0 105573 3018
F344 ventricular late potential 4-methyl-2-(piperidin-1-yl)-quinoline (1 mg/g) (for 0.5 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. heart electrical impulse conduction trait male  days 3 0.86 % 0.21 0.36 electrocardiography 0.0 CV% 105580 3018
F344 cerebrum infarct volume to total cerebrum volume ratio isoflurane (1.5 %) (for 4 hours) then rolipram (3 mg/kg) then middle cerebral artery occlusion (for 1 hours) Yang F, et al., J Pharm Pharm Sci. 2014;17(3):362-70. cerebrum integrity trait male  days 18 25.0 % 3.0 12.73 ex vivo light microscopy with histochemistry and digital image analysis 0.0 cerebral ischemia 1 days 106195 3029
F344 number of lower body licking events 4-methyl-2-(piperidin-1-yl)-quinoline (1 mg/kg) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 4 2.0 null 2.0 4.0 visual assessment of in vivo video recording 1500.0 number of lower body licking events 105556 3018
F344 number of lower body licking events sucrose (10 %) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 3 58.0 null 12.92 22.38 visual assessment of in vivo video recording 1500.0 lower body licking event 105560 3018
F344 number of lower body licking events 4-methyl-2-(piperidin-1-yl)-quinoline (0.75 mg/kg) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 3 19.25 null 7.19 12.45 visual assessment of in vivo video recording 1500.0 lower body licking event 105561 3018
F344 mean arterial blood pressure control condition Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. arterial blood pressure trait male  days 2 111.04 mmHg unspecified method 0.0 105568 3018
F344 mean arterial blood pressure 4-methyl-2-(piperidin-1-yl)-quinoline (1 mg/kg) (for 0.5 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. arterial blood pressure trait male  days 3 120.97 mmHg unspecified method 0.0 105571 3018
F344 measurement of the 50% threshold of mechanical stimulus needed to elicit evasive reaction 4-methyl-2-(piperidin-1-yl)-quinoline (0.75 mg/kg) (for 0.5 hours) then Allyl isothiocyanate (0.5 null) (for 0.5 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. tactile sensory behavior trait male  days 4 14.77 g 2.3 4.6 von Frey assay 1500.0 von Frey assay (MMO:0000752) both paws 105567 3018
F344 ST interval control condition Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. heart electrical impulse conduction trait male  days 3 53.73 ms 3.65 6.32 electrocardiography 0.0 105590 3018
F344 number of abdominal retractions 4-methyl-2-(piperidin-1-yl)-quinoline (0.5 mg/kg) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 4 31.67 null 2.18 4.36 visual assessment of in vivo video recording 1500.0 stretch/retract abdomon 105558 3018
F344 number of lower body licking events 4-methyl-2-(piperidin-1-yl)-quinoline (0.5 mg/kg) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 4 21.67 null 4.9 9.8 visual assessment of in vivo video recording 1500.0 lower body licking event 105555 3018
F344 mean arterial blood pressure sucrose (10 %) (for 0.5 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. arterial blood pressure trait male  days 2 123.56 mmHg unspecified method 0.0 105570 3018
F344 heart rate control condition Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. heart pumping trait male  days 3 449.89 beats/min 16.8 29.1 electrocardiography 0.0 105574 3018
F344 PR interval 4-methyl-2-(piperidin-1-yl)-quinoline (1 mg/g) (for 0.5 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. heart electrical impulse conduction trait male  days 3 29.6 ms 0.28 0.48 electrocardiography 0.0 pq interval 105584 3018
F344 QRS duration 4-methyl-2-(piperidin-1-yl)-quinoline (1 mg/g) (for 0.5 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. heart electrical impulse conduction trait male  days 3 15.41 ms 0.56 0.97 electrocardiography 0.0 pq interval 105588 3018
F344 QT interval control condition Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. heart electrical impulse conduction trait male  days 3 68.11 ms 4.56 7.9 electrocardiography 0.0 105594 3018
F344 cerebrum infarct volume to total cerebrum volume ratio isoflurane (1.5 %) (for 4 hours) then vehicle control condition then middle cerebral artery occlusion (for 1 hours) Yang F, et al., J Pharm Pharm Sci. 2014;17(3):362-70. cerebrum integrity trait male  days 18 11.0 % 2.0 8.49 ex vivo light microscopy with histochemistry and digital image analysis 0.0 cerebral ischemia 1 days 106172 3029
F344 cerebrum infarct volume to total cerebrum volume ratio isoflurane (1.5 %) (for 4 hours) then vehicle control condition then middle cerebral artery occlusion (for 1 hours) Yang F, et al., J Pharm Pharm Sci. 2014;17(3):362-70. cerebrum integrity trait male  days 6 18.0 % 6.0 14.7 ex vivo light microscopy with histochemistry and digital image analysis 0.0 cerebral ischemia 1 days 106361 3029
F344 measurement of the 50% threshold of mechanical stimulus needed to elicit evasive reaction 4-methyl-2-(piperidin-1-yl)-quinoline (0.15 mg/kg) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) (for 0.5 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. tactile sensory behavior trait male  days 4 11.35 g 1.62 3.24 von Frey assay 1500.0 von Frey assay (MMO:0000752) right paw 109702 3018
F344 number of abdominal retractions 4-methyl-2-(piperidin-1-yl)-quinoline (0.75 mg/kg) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 4 32.5 null 9.26 16.04 visual assessment of in vivo video recording 1500.0 retract abdomen 105563 3018
F344 measurement of the 50% threshold of mechanical stimulus needed to elicit evasive reaction sucrose (10 %) (for 0.5 hours) then Allyl isothiocyanate (0.5 null) (for 0.5 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. tactile sensory behavior trait male  days 4 2.88 g 0.44 0.88 von Frey assay 1500.0 von Frey assay (MMO:0000752) both paws 105566 3018
F344 heart rate 4-methyl-2-(piperidin-1-yl)-quinoline (1 mg/kg) (for 0.5 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. heart pumping trait male  days 3 424.89 beats/min 2.65 4.59 electrocardiography 0.0 105576 3018
F344 ventricular late potential control condition Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. heart electrical impulse conduction trait male  days 3 1.29 % 0.14 0.24 electrocardiography 0.0 CV% 105578 3018
F344 QT interval 4-methyl-2-(piperidin-1-yl)-quinoline (1 mg/g) (for 0.5 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. heart electrical impulse conduction trait male  days 3 72.02 ms 1.68 2.91 electrocardiography 0.0 105596 3018
F344 measurement of the 50% threshold of mechanical stimulus needed to elicit evasive reaction 4-methyl-2-(piperidin-1-yl)-quinoline (0.15 mg/kg) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) (for 0.5 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. tactile sensory behavior trait male  days 4 10.85 g 0.78 1.56 von Frey assay 1500.0 von Frey assay (MMO:0000752) left paw 109701 3018
F344 number of lower body licking events Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 7 49.75 null 4.5 11.91 visual assessment of in vivo video recording 1500.0 lower body licking event 105548 3018
F344 number of lower body licking events sucrose (10 %) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 4 52.14 null 7.27 14.54 visual assessment of in vivo video recording 1500.0 lower body licking event 105554 3018
F344 number of abdominal retractions sucrose (10 %) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 4 68.28 null 16.67 33.34 visual assessment of in vivo video recording 1500.0 stretch/retract abdomon 105557 3018
F344 number of lower body licking events sucrose (10 %) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 4 58.0 null 7.27 12.92 visual assessment of in vivo video recording 1500.0 licking abdomen events 105564 3018
F344 number of lower body licking events 4-methyl-2-(piperidin-1-yl)-quinoline (0.75 mg/kg) (for 0.5 hours) then Allyl isothiocyanate (0.5 %) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. chemical nociception trait male  days 4 19.25 null 4.9 7.19 visual assessment of in vivo video recording 1500.0 licking abdomen events 105565 3018
F344 mean arterial blood pressure control condition Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. arterial blood pressure trait male  days 3 113.42 mmHg unspecified method 0.0 105569 3018
F344 mean arterial blood pressure sucrose (10 %) (for 1 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. arterial blood pressure trait male  days 2 127.7 mmHg unspecified method 0.0 105572 3018
F344 PR interval control condition Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. heart electrical impulse conduction trait male  days 3 28.92 ms 1.54 2.67 electrocardiography 0.0 pq 105582 3018
F344 QRS duration control condition Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. heart electrical impulse conduction trait male  days 3 15.4 ms 0.92 1.59 electrocardiography 0.0 105586 3018
F344 ST interval 4-methyl-2-(piperidin-1-yl)-quinoline (1 mg/g) (for 0.5 hours) Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. heart electrical impulse conduction trait male  days 3 57.59 ms 1.1 1.91 electrocardiography 0.0 105592 3018